Home » Topics » Regulatory » Patents

Patents
RSS

Roche describes novel TAAR1 ligands and their use as antidepressants

April 7, 2009

Recent GSK patents describe novel Akt inhibitors for cancer treatment

April 7, 2009

Novel histone deacetylase inhibitors presented by ArQule

April 7, 2009

Novel mu-opioid receptor ligands developed by OSI Prosidion for the treatment of obesity

April 6, 2009

Novel bile acid responsive receptor ligands discovered by Kalypsus

April 6, 2009

Orchid Research Laboratories presents novel monoamine oxidase inhibitors

April 6, 2009

Novel Raf kinase inhibitors presented by GlaxoSmithKline

April 6, 2009

Novel b-Raf inhibitors claimed by Takeda

April 6, 2009

AstraZeneca claims novel 2-pyrazinylbenzimidazole derivatives for cancer treatment

April 3, 2009

Substituted CC-1065 analogues claimed by Syntarga

April 3, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...